Trial Profile
Therapeutic compliance in terms of quality of life with rivaroxaban for prevntion of stroke in patients with non-valvular atrial fibrilation: An observational, prospective, multicenter, longitudinal study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms CUMRIVAFA
- 22 Sep 2017 Results published in the Quality of Life Research.
- 21 Sep 2017 New trial record